News

The FDA has issued a warning that azithromycin should not be used to prevent bronchiolitis obliterans syndrome in patients with hematologic malignancies who undergo HSCT.

Syphilis continues to spread in indigenous populations residing in 4 jurisdictions throughout Australia.

While we are focused on antimicrobial resistance to drugs, we may be missing another microbial menace.

Gram-negative organisms are showing up at higher rates in seriously ill pneumonia patients. What are the best antibiotics to prescribe, given the real risk of death and the need to avoid contributing to drug resistance?

The growing incidence of tick-borne infections has clinicians and researchers calling for new, effective prevention and control methods.

Investigators from Yale School of Medicine, in collaboration with Novartis Vaccines, Inc, have developed a novel vaccine that successfully protects against malaria infection in a mouse model.

New cases of Ebola were confirmed in the North Kivu Province, just 1 week after the outbreak in the Equator Province ended.

Better diagnostics and treatment are needed for Mycoplasma genitalium—a lesser-known sexually-transmitted infection estimated to infect up to 3% of the population in many countries.

Science doesn’t support legal punishment of HIV-positive people.

New data reveals that mcr-1 carrying Enterobacteriaceae can be detected on hospital surfaces, indicating that this plasmid has the ability to spread in key human pathogens.

A new CDC analysis underscores the need for HIV testing programs in the southern part of the United States to improve linkage medical care among HIV-positive black men who have sex with men (MSM).

A simulation exercise conducted by the Johns Hopkins Center for Health Security emphasizes the need for new policies and procedures to reduce negative outcomes in future pandemics.

Legionella bacteria were detected in the water supply of a Bronx hospital as cases of Legionnaires’ disease rise in Lower Washington Heights cluster.

Requiring reporting of health care-associated infections for reimbursement is a lot messier than one might think.

We’ve rounded up a list of important US Food and Drug Administration (FDA) recalls from this week.

Since August of 2017, there have been 1,170 cases of hepatitis A in Kentucky, resulting in 658 hospitalizations and 8 deaths.

Genital shedding in herpes patients is even more common than genital lesions. Can a new way of testing for the disease streamline the treatment process?

OSA is largely untreated in HIV patients, and this lack of treatment likely contributes to further comorbidity complications associated with the virus.

As more and more health care organizations embrace environmental sustainability, experts say epidemiologists need to have a seat at the table to stave off infection control and prevention concerns.

The FDA has indicated that whey powder is a common ingredient in 3 products recalled this week for potential Salmonella contamination.

We know we have a problem with isolation precaution compliance, but just how bad is it?

Eradication of HCV in patients with HIV results in reduction of CD4+ and CD8+ T cell immune activation.

At week 96, 73.1% of patients infected with HIV-1 and treated with once-daily doravirine + other ART medications, achieved viral suppression.

Investigators report results of the first randomized clinical trial to test a novel strategy to wake up and kill dormant HIV hiding in reservoir cells.

Millions with viral hepatitis go undiagnosed and untreated.

Dolutegravir and lamivudine combination regimen met primary endpoint in 2 phase 3 studies of treatment-naïve patients with HIV.

After 42 days without any new confirmed cases, the ninth Ebola outbreak in the Democratic Republic of the Congo is officially over.

Mosaic-based vaccine regimen maintained humoral and cellular HIV immune responses according to long-term data from APPROACH.